Back to results
US 2009/0263387 A1Published application
Neutralization of GM-CSF for the Treatment of Heart Failure
AssigneeKaloBios Pharmaceuticals, Inc.
InventorsChristopher R. Bebbington, Geoffrey T. Yarranton
Life of this patent
Estimating the term…
Abstract
This invention relates to methods of treating a patient suffering from heart failure, or a patient at risk for heart failure, using a GM-CSF antagonist.
Claims35
A method for treating a patient that has heart failure, is at risk for heart failure subsequent to an ischemic episode, or has a cardiomyopathy, the method comprising administering a therapeutically effective amount of a GM-CSF antagonist to the patient.
Dependencies are inferred from the claim text.